Fact Sheet
Trends in the use of antipsychotics in Canada, 2019–2022
IQVIA Snapshot - Prevalence and Treatment of Mental Health Disorders
Feb 16, 2024
This Snapshot presents some highlights obtained from IQVIA’s Dashboard on prescriptions dispensed for antipsychotics. The data used to produce this Snapshot includes the two existing generations of antipsychotics: first-generation (typical) antipsychotics, which are used increasingly less and whose volumes in the data studied are the first and second-generation (atypical) antipsychotics, which, in oral form, are by far the most widely used. This generation also includes long-lasting injections (depot form), which are dispensed between once a week and once a month. Prevalence and demographic characteristics of consumption in the general Canadian population are presented for 2019, 2020, 2021, and 2022.